Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Hajime Uno, PhD


No Ratings Available - Why Not?

Researcher

  • Assistant Professor, Harvard Medical School

Contact Information

  • Office Phone Number617-632-6893
  • Fax617-632-2270

Research

Research Abstract

Dr. Hajime Uno is biostatistician devoted to collaborative clinical and methodological research to promote improved understanding of human disease.  His statistical methodological research focuses on evaluating prediction models for clinical outcomes based on standard clinical parameter and biomarkers.

OptBand: optimization-based confidence bands for functions to characterize time-to-event distributions. Lifetime Data Anal. 2021 Apr 13.
View in: PubMed

Familial burden and other clinical factors associated with various types of cancer in individuals with Lynch syndrome. Gastroenterology. 2021 Mar 25.
View in: PubMed

Implementing Systematic Genetic Counseling and Multigene Germline Testing for Individuals With Pancreatic Cancer. JCO Oncol Pract. 2021 Feb; 17(2):e236-e247.
View in: PubMed

Acrolein and other toxicant exposures in relation to cardiovascular disease among marijuana and tobacco smokers in a longitudinal cohort of HIV-positive and negative adults. EClinicalMedicine. 2021 Jan; 31:100697.
View in: PubMed

Erratum to "ROC curves for clinical prediction models part 1. ROC plots showed no added value above the AUC when evaluating the performance of clinical prediction models" [J Clin Epidemiol. 126C(2020):207-16]. J Clin Epidemiol. 2021 Feb; 130:171-173.
View in: PubMed

Comparison of Colorectal and Endometrial Microsatellite Instability Tumor Analysis and Premm5 Risk Assessment for Predicting Pathogenic Germline Variants on Multigene Panel Testing. J Clin Oncol. 2020 12 01; 38(34):4086-4094.
View in: PubMed

Empirical power comparison of statistical tests in contemporary phase III randomized controlled trials with time-to-event outcomes in oncology. Clin Trials. 2020 12; 17(6):597-606.
View in: PubMed

The Effect of Disclosing Life Expectancy Information on Patients' Prognostic Understanding: Secondary Outcomes From a Multicenter Randomized Trial of a Palliative Chemotherapy Educational Intervention. J Pain Symptom Manage. 2021 01; 61(1):1-11.e3.
View in: PubMed

Characterizing germline APC and MUTYH variants in Ashkenazi Jews compared to other individuals. Fam Cancer. 2021 Apr; 20(2):111-116.
View in: PubMed

Effectiveness of a Multimedia Educational Intervention to Improve Understanding of the Risks and Benefits of Palliative Chemotherapy in Patients With Advanced Cancer: A Randomized Clinical Trial. JAMA Oncol. 2020 08 01; 6(8):1265-1270.
View in: PubMed

ROC curves for clinical prediction models part 1. ROC plots showed no added value above the AUC when evaluating the performance of clinical prediction models. J Clin Epidemiol. 2020 10; 126:207-216.
View in: PubMed

Assessment of Temporal Selection Bias in Genomic Testing in a Cohort of Patients With Cancer. JAMA Netw Open. 2020 06 01; 3(6):e206976.
View in: PubMed

Patterns and predictors of cancer-related fatigue in ovarian and endometrial cancers: 1-year longitudinal study. Cancer. 2020 Aug 01; 126(15):3526-3533.
View in: PubMed

On permutation tests for comparing restricted mean survival time with small sample from randomized trials. Stat Med. 2020 09 10; 39(20):2655-2670.
View in: PubMed

Racial and Ethnic Differences in Communication and Care for Children With Advanced Cancer. J Pain Symptom Manage. 2020 10; 60(4):782-789.
View in: PubMed

Is the Log-Rank and Hazard Ratio Test/Estimation the Best Approach for Primary Analysis for All Trials? J Clin Oncol. 2020 06 10; 38(17):2000-2001.
View in: PubMed

Loss of tetherin antagonism by Nef impairs SIV replication during acute infection of rhesus macaques. PLoS Pathog. 2020 04; 16(4):e1008487.
View in: PubMed

On the empirical choice of the time window for restricted mean survival time. Biometrics. 2020 12; 76(4):1157-1166.
View in: PubMed

Statistical Test/Estimation Methods Used in Contemporary Phase III Cancer Randomized Controlled Trials with Time-to-Event Outcomes. Oncologist. 2020 02; 25(2):91-93.
View in: PubMed

Statistical Test/Estimation Methods Used in Contemporary Phase III Cancer Randomized Controlled Trials with Time-to-Event Outcomes. Oncologist. 2019 Nov 19.
View in: PubMed

Clinical Factors Associated with Urinary Tract Cancer in Individuals with Lynch Syndrome. Cancer Epidemiol Biomarkers Prev. 2020 01; 29(1):193-199.
View in: PubMed

Goals of care discussions for patients with blood cancers: Association of person, place, and time with end-of-life care utilization. Cancer. 2020 02 01; 126(3):515-522.
View in: PubMed

Unrealistic parental expectations for cure in poor-prognosis childhood cancer. Cancer. 2020 01 15; 126(2):416-424.
View in: PubMed

Patient-preferred outcomes measurement after post-mastectomy radiation therapy and immediate reconstruction. Breast J. 2020 02; 26(2):319-321.
View in: PubMed

Assessing Clinical Equivalence in Oncology Biosimilar Trials With Time-to-Event Outcomes. JNCI Cancer Spectr. 2019 Dec; 3(4):pkz058.
View in: PubMed

Spending for Advanced Cancer Diagnoses: Comparing Recurrent Versus De Novo Stage IV Disease. J Oncol Pract. 2019 07; 15(7):e616-e627.
View in: PubMed

Unifying Design and Analysis for Superiority and Noninferiority Trials With Appropriate End Point. JAMA Surg. 2019 05 01; 154(5):466-467.
View in: PubMed

Hospitalization Risk During Chemotherapy for Advanced Cancer: Development and Validation of Risk Stratification Models Using Real-World Data. JCO Clin Cancer Inform. 2019 04; 3:1-10.
View in: PubMed

Performance of Cancer Recurrence Algorithms After Coding Scheme Switch From International Classification of Diseases 9th Revision to International Classification of Diseases 10th Revision. JCO Clin Cancer Inform. 2019 03; 3:1-9.
View in: PubMed

Increased risk of anal squamous cell carcinoma in HIV-positive men with prior hepatitis B virus infection. AIDS. 2019 01 27; 33(1):145-152.
View in: PubMed

Effect of marijuana smoking on pulmonary disease in HIV-infected and uninfected men: a longitudinal cohort study. EClinicalMedicine. 2019 Jan; 7:55-64.
View in: PubMed

Determining the Time of Cancer Recurrence Using Claims or Electronic Medical Record Data. JCO Clin Cancer Inform. 2018 12; 2:1-10.
View in: PubMed

Moving beyond the conventional stratified analysis to estimate an overall treatment efficacy with the data from a comparative randomized clinical study. Stat Med. 2019 03 15; 38(6):917-932.
View in: PubMed

Low T-cell subsets prior to development of virus-associated cancer in HIV-seronegative men who have sex with men. Cancer Causes Control. 2018 Nov; 29(11):1131-1142.
View in: PubMed

Hospitalization and Survival of Medicare Patients Treated With Carboplatin Plus Paclitaxel or Pemetrexed for Metastatic, Nonsquamous, Non-Small Cell Lung Cancer. JAMA Netw Open. 2018 10 05; 1(6):e183023.
View in: PubMed

Commentary: PREMM5 threshold of 2.5% is recommended to improve identification of PMS2 carriers. Fam Cancer. 2018 10; 17(4):567.
View in: PubMed

Impact of Antiretroviral Regimens on Cerebrospinal Fluid Viral Escape in a Prospective Multicohort Study of Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-1-Infected Adults in the United States. Clin Infect Dis. 2018 09 28; 67(8):1182-1190.
View in: PubMed

How Do the Accrual Pattern and Follow-Up Duration Affect the Hazard Ratio Estimate When the Proportional Hazards Assumption Is Violated? Oncologist. 2019 07; 24(7):867-871.
View in: PubMed

Interpreting the Association of First-in-Class Immune Checkpoint Inhibition and Targeted Therapy With Survival in Patients With Stage IV Melanoma. JAMA Oncol. 2018 08 01; 4(8):1135-1136.
View in: PubMed

Estimating and Interpreting the Overall Survival Benefit of Checkpoint Inhibitors via Meta-analysis. JAMA Oncol. 2018 08 01; 4(8):1137-1138.
View in: PubMed

Medical Care Costs for Recurrent versus De Novo Stage IV Cancer by Age at Diagnosis. Health Serv Res. 2018 12; 53(6):5106-5128.
View in: PubMed

Comparing Survival After Recurrent vs De Novo Stage IV Advanced Breast, Lung, and Colorectal Cancer. JNCI Cancer Spectr. 2018 Apr; 2(2):pky024.
View in: PubMed

Estrogen-receptor status and risk of contralateral breast cancer following DCIS. Breast Cancer Res Treat. 2018 Oct; 171(3):777-781.
View in: PubMed

Quantification of Long-term Survival Benefit in a Comparative Oncology Clinical Study. JAMA Oncol. 2018 06 01; 4(6):881-882.
View in: PubMed

Interactive or static reports to guide clinical interpretation of cancer genomics. J Am Med Inform Assoc. 2018 05 01; 25(5):458-464.
View in: PubMed

Assessing Metronomic Chemotherapy for Progressive Pediatric Solid Malignant Tumors. JAMA Oncol. 2018 05 01; 4(5):743.
View in: PubMed

Adding a new analytical procedure with clinical interpretation in the tool box of survival analysis. Ann Oncol. 2018 05 01; 29(5):1092-1094.
View in: PubMed

A flexible and coherent test/estimation procedure based on restricted mean survival times for censored time-to-event data in randomized clinical trials. Stat Med. 2018 07 10; 37(15):2307-2320.
View in: PubMed

Zoledronic Acid Dosing in Patients With Metastatic Breast Cancer. JAMA Oncol. 2018 04 01; 4(4):585.
View in: PubMed

Development, Validation, and Dissemination of a Breast Cancer Recurrence Detection and Timing Informatics Algorithm. J Natl Cancer Inst. 2018 03 01; 110(3):273-281.
View in: PubMed

Evaluating Noninferiority With Clinically Interpretable Statistics for the PROSELICA Study to Assess Treatment Efficacy of a Reduced Dose of Cabazitaxel for Treating Metastatic Prostate Cancer. J Clin Oncol. 2018 03 10; 36(8):825-826.
View in: PubMed

Axillary vs Sentinel Lymph Node Dissection in Women With Invasive Breast Cancer. JAMA. 2018 01 16; 319(3):306.
View in: PubMed

Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab as a Result of Adverse Events Lived Significantly Longer Than Patients Who Continued Treatment. J Clin Oncol. 2018 03 01; 36(7):720-721.
View in: PubMed

Detecting Lung and Colorectal Cancer Recurrence Using Structured Clinical/Administrative Data to Enable Outcomes Research and Population Health Management. Med Care. 2017 12; 55(12):e88-e98.
View in: PubMed

Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio. JAMA Oncol. 2017 12 01; 3(12):1692-1696.
View in: PubMed

Poor performance of clinical prediction models: the harm of commonly applied methods. J Clin Epidemiol. 2018 06; 98:133-143.
View in: PubMed

Restricted Mean Survival Time as a Measure to Interpret Clinical Trial Results. JAMA Cardiol. 2017 11 01; 2(11):1179-1180.
View in: PubMed

Efficiency of two sample tests via the restricted mean survival time for analyzing event time observations. Biometrics. 2018 06; 74(2):694-702.
View in: PubMed

Decision on performing interim analysis for comparative clinical trials. Contemp Clin Trials Commun. 2017 Sep; 7:224-230.
View in: PubMed

Marijuana Use Impacts Midlife Cardiovascular Events in HIV-Infected Men. Clin Infect Dis. 2017 Aug 15; 65(4):626-635.
View in: PubMed

Overall Survival in the Randomized Phase II Study Investigating Pazopanib Versus Weekly Paclitaxel in Relapsed or Progressive Urothelial Cancer. J Clin Oncol. 2017 10 10; 35(29):3373.
View in: PubMed

KIR3DL01 upregulation on gut natural killer cells in response to SIV infection of KIR- and MHC class I-defined rhesus macaques. PLoS Pathog. 2017 Jul; 13(7):e1006506.
View in: PubMed

Survival after recurrence of stage I-III breast, colorectal, or lung cancer. Cancer Epidemiol. 2017 08; 49:186-194.
View in: PubMed

Long-term nitrite inhalant exposure and cancer risk in MSM. AIDS. 2017 05 15; 31(8):1169-1180.
View in: PubMed

Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome. J Clin Oncol. 2017 Jul 01; 35(19):2165-2172.
View in: PubMed

Racial differences in prostate cancer risk in young HIV-positive and HIV-negative men: a prospective cohort study. Cancer Causes Control. 2017 Jul; 28(7):767-777.
View in: PubMed

Long-term nitrite inhalant exposure and cancer risk in men who have sex with men: a prospective cohort study. AIDS. 2017 Mar 18.
View in: PubMed

Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer. J Clin Oncol. 2017 Apr 01; 35(10):1086-1095.
View in: PubMed

Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy. Science. 2017 01 20; 355(6322).
View in: PubMed

Association of Regional Intensity of Ductal Carcinoma In Situ Treatment With Likelihood of Breast Preservation. JAMA Oncol. 2017 Jan 01; 3(1):101-104.
View in: PubMed

How to Summarize the Safety Profile of Epoetin Alfa Versus Best Standard of Care in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy? J Clin Oncol. 2016 11 01; 34(31):3818.
View in: PubMed

Safety Study of Salmeterol in Asthma in Adults. N Engl J Med. 2016 09 15; 375(11):1097.
View in: PubMed

Reply to comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer. Cancer. 2016 10 15; 122(20):3244-3245.
View in: PubMed

Neratinib after trastuzumab in patients with HER2-positive breast cancer. Lancet Oncol. 2016 05; 17(5):e176.
View in: PubMed

Comparative effectiveness of stereotactic radiosurgery versus whole-brain radiation therapy for patients with brain metastases from breast or non-small cell lung cancer. Cancer. 2016 Jul 01; 122(13):2091-100.
View in: PubMed

Influence of patient and provider characteristics on quality of care for the myelodysplastic syndromes. Br J Haematol. 2016 06; 173(5):713-21.
View in: PubMed

Nivolumab in Nonsquamous Non-Small-Cell Lung Cancer. N Engl J Med. 2016 02 04; 374(5):492-3.
View in: PubMed

Detection and prognostic value of pulmonary congestion by lung ultrasound in ambulatory heart failure patients. Eur Heart J. 2016 Apr 14; 37(15):1244-51.
View in: PubMed

Intensity of Medical Interventions between Diagnosis and Death in Patients with Advanced Lung and Colorectal Cancer: A CanCORS Analysis. J Palliat Med. 2016 Jan; 19(1):42-50.
View in: PubMed

On the restricted mean survival time curve in survival analysis. Biometrics. 2016 Mar; 72(1):215-21.
View in: PubMed

Detecting Lung and Colorectal Cancer Recurrence Using Structured Clinical/Administrative Data to Enable Outcomes Research and Population Health Management. Med Care. 2015 Jul 29.
View in: PubMed

Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies. Ann Intern Med. 2015 Jul 21; 163(2):127-34.
View in: PubMed

A versatile test for equality of two survival functions based on weighted differences of Kaplan-Meier curves. Stat Med. 2015 Dec 10; 34(28):3680-95.
View in: PubMed

Biological Subtype Predicts Risk of Locoregional Recurrence After Mastectomy and Impact of Postmastectomy Radiation in a Large National Database. Int J Radiat Oncol Biol Phys. 2015 Nov 01; 93(3):622-30.
View in: PubMed

Adverse Outcomes After Palliative Radiation Therapy for Uncomplicated Spine Metastases: Role of Spinal Instability and Single-Fraction Radiation Therapy. Int J Radiat Oncol Biol Phys. 2015 Oct 01; 93(2):373-81.
View in: PubMed

Clinician assessment of potentially avoidable hospitalization in patients with cancer. J Clin Oncol. 2014 Oct 20; 32(30_suppl):4.
View in: PubMed

Acute hospital care is the chief driver of regional spending variation in Medicare patients with advanced cancer. Health Aff (Millwood). 2014 Oct; 33(10):1793-800.
View in: PubMed

Derivation and validation of the SEER-Medicare myelodysplastic syndromes risk score (SMMRS). Leuk Res. 2014 Dec; 38(12):1420-4.
View in: PubMed

Financial hardship and the intensity of medical care received near death. Psychooncology. 2015 May; 24(5):572-8.
View in: PubMed

Interinstitutional variation in management decisions for treatment of 4 common types of cancer: A multi-institutional cohort study. Ann Intern Med. 2014 Jul 01; 161(1):20-30.
View in: PubMed

Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis. J Clin Oncol. 2014 Aug 01; 32(22):2380-5.
View in: PubMed

Effects of bracing in adolescents with idiopathic scoliosis. N Engl J Med. 2014 02 13; 370(7):680.
View in: PubMed

Identification of potentially avoidable hospitalizations in patients with GI cancer. J Clin Oncol. 2014 Feb 20; 32(6):496-503.
View in: PubMed

Hemoglobin stability in patients with anemia, CKD, and type 2 diabetes: an analysis of the TREAT (Trial to Reduce Cardiovascular Events With Aranesp Therapy) placebo arm. Am J Kidney Dis. 2013 Feb; 61(2):238-46.
View in: PubMed

A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data. Stat Med. 2013 Jun 30; 32(14):2430-42.
View in: PubMed

Utilizing the integrated difference of two survival functions to quantify the treatment contrast for designing, monitoring, and analyzing a comparative clinical study. Clin Trials. 2012 Oct; 9(5):570-7.
View in: PubMed

Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection. . 2012 Jul 01; 60(3):234-43.
View in: PubMed

Mortality rates in trials of subjects with type 2 diabetes. J Am Heart Assoc. 2012 Feb; 1(1):8-15.
View in: PubMed

Functional pathway analysis in acute myeloid leukemia using single cell network profiling assay: effect of specimen source (bone marrow or peripheral blood) on assay readouts. Cytometry B Clin Cytom. 2012 May; 82(3):158-72.
View in: PubMed

Stroke in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia treated with Darbepoetin Alfa: the trial to reduce cardiovascular events with Aranesp therapy (TREAT) experience. Circulation. 2011 Dec 20; 124(25):2903-8.
View in: PubMed

Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT). Am Heart J. 2011 Oct; 162(4):748-755.e3.
View in: PubMed

Impact of high-risk classification by FISH: an eastern cooperative oncology group (ECOG) study E4A03. Br J Haematol. 2011 Nov; 155(3):340-8.
View in: PubMed

Impact of gene expression profiling-based risk stratification in patients with myeloma receiving initial therapy with lenalidomide and dexamethasone. Blood. 2011 Oct 20; 118(16):4359-62.
View in: PubMed

Plasma sCD14 is a biomarker associated with impaired neurocognitive test performance in attention and learning domains in HIV infection. . 2011 Aug 15; 57(5):371-9.
View in: PubMed

Prognostic assessment of estimated glomerular filtration rate by the new Chronic Kidney Disease Epidemiology Collaboration equation in comparison with the Modification of Diet in Renal Disease Study equation. Am Heart J. 2011 Sep; 162(3):548-54.
View in: PubMed

Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD. Am J Kidney Dis. 2011 Nov; 58(5):717-28.
View in: PubMed

Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertension. J Renin Angiotensin Aldosterone Syst. 2011 Dec; 12(4):483-90.
View in: PubMed

Relationship between improvement in left ventricular dyssynchrony and contractile function and clinical outcome with cardiac resynchronization therapy: the MADIT-CRT trial. Eur Heart J. 2011 Jul; 32(14):1720-9.
View in: PubMed

Circumstances and outcomes of sudden unexpected death in patients with high-risk myocardial infarction: implications for prevention. Circulation. 2011 Jun 14; 123(23):2674-80.
View in: PubMed

Dyssynchrony, contractile function, and response to cardiac resynchronization therapy. Circ Heart Fail. 2011 Jul; 4(4):433-40.
View in: PubMed

Survival outcomes in elderly patients with plasma cell myeloma: The three-decade Eastern Cooperative Oncology Group (ECOG) experience. J Clin Oncol. 2011 May 20; 29(15_suppl):8021.
View in: PubMed

Graphical procedures for evaluating overall and subject-specific incremental values from new predictors with censored event time data. Biometrics. 2011 Dec; 67(4):1389-96.
View in: PubMed

Opposing effects of ß blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery disease. Am J Cardiol. 2011 Jun 15; 107(12):1705-9.
View in: PubMed

Outcome prediction in sepsis combined use of genetic polymorphisms - A study in Japanese population. Cytokine. 2011 Apr; 54(1):79-84.
View in: PubMed

On the C-statistics for evaluating overall adequacy of risk prediction procedures with censored survival data. Stat Med. 2011 May 10; 30(10):1105-17.
View in: PubMed

Darbepoetin alfa impact on health status in diabetes patients with kidney disease: a randomized trial. Clin J Am Soc Nephrol. 2011 Apr; 6(4):845-55.
View in: PubMed

Longitudinal and circumferential strain rate, left ventricular remodeling, and prognosis after myocardial infarction. J Am Coll Cardiol. 2010 Nov 23; 56(22):1812-22.
View in: PubMed

The inter-relationship of diabetes and left ventricular systolic function on outcome after high-risk myocardial infarction. Eur J Heart Fail. 2010 Nov; 12(11):1229-37.
View in: PubMed

Erythropoietic response and outcomes in kidney disease and type 2 diabetes. N Engl J Med. 2010 Sep 16; 363(12):1146-55.
View in: PubMed

Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999. Blood. 2010 Nov 18; 116(20):4077-85.
View in: PubMed

Pathogenesis of sudden unexpected death in a clinical trial of patients with myocardial infarction and left ventricular dysfunction, heart failure, or both. Circulation. 2010 Aug 10; 122(6):597-602.
View in: PubMed

Clinical consequences of road traffic injuries among the elderly in Japan. BMC Public Health. 2010 Jun 28; 10:375.
View in: PubMed

Calibrating parametric subject-specific risk estimation. Biometrika. 2010 Jun; 97(2):389-404.
View in: PubMed

Mechanical dyssynchrony after myocardial infarction in patients with left ventricular dysfunction, heart failure, or both. Circulation. 2010 Mar 09; 121(9):1096-103.
View in: PubMed

Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial. Biol Blood Marrow Transplant. 2010 Jul; 16(7):1005-17.
View in: PubMed

Predicted Interval Plots (PIPS): A Graphical Tool for Data Monitoring of Clinical Trials. Stat Biopharm Res. 2009 Nov 01; 1(4):348-355.
View in: PubMed

Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial. Br J Haematol. 2009 Dec; 147(5):677-80.
View in: PubMed

Baseline characteristics in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT). Am J Kidney Dis. 2009 Jul; 54(1):59-69.
View in: PubMed

Long-lasting responses after four doses of rituximab in Waldenström's macroglobulinemia: Clinical value of minor responses: A follow-up of the Eastern Cooperative Oncology Group E3A98 trial. J Clin Oncol. 2009 May 20; 27(15_suppl):8513.
View in: PubMed

Left atrial remodelling in patients with myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALIANT Echo study. Eur Heart J. 2009 Jan; 30(1):56-65.
View in: PubMed

The short treatment with the angiotensin receptor blocker candesartan surveyed by telemedicine (STAR CAST) study: rationale and study design. Hypertens Res. 2008 Oct; 31(10):1843-9.
View in: PubMed

Diagnostic performance of PET/CT in differentiation of malignant and benign non-solid solitary pulmonary nodules. Ann Nucl Med. 2008 Aug; 22(7):571-7.
View in: PubMed

Development and verification of a prediction model using serum tumor markers to predict the response to chemotherapy of patients with metastatic or recurrent breast cancer. J Cancer Res Clin Oncol. 2008 Nov; 134(11):1199-206.
View in: PubMed

Which factors will make the duration short between last palliative chemotherapy and death? J Clin Oncol. 2008 May 20; 26(15_suppl):20575.
View in: PubMed

Development and validation of diagnostic prediction model for solitary pulmonary nodules. Respirology. 2007 Nov; 12(6):856-62.
View in: PubMed

Prediction of response and prognostic factors for Ewing family of tumors in a low incidence population. J Cancer Res Clin Oncol. 2008 Mar; 134(3):389-95.
View in: PubMed

Solitary pulmonary granuloma caused by Mycobacterium avium-intracellulare complex. Int J Tuberc Lung Dis. 2007 Feb; 11(2):215-21.
View in: PubMed

Genomic characterization of multiple clinical phenotypes of cancer using multivariate linear regression models. Bioinformatics. 2007 Mar 15; 23(6):732-8.
View in: PubMed

Prediction of response to repeat utilization of anthracycline in recurrent breast cancer patients previously administered anthracycline-containing chemotherapeutic regimens as neoadjuvant or adjuvant chemotherapy. Breast Cancer Res Treat. 2007 Jul; 103(3):313-8.
View in: PubMed

Diagnostic accuracy of CT-guided percutaneous cutting needle biopsy for thymic tumours. Clin Radiol. 2006 Sep; 61(9):771-5.
View in: PubMed

Prediction of lung adenocarcinoma without vessel invasion: a CT scan volumetric analysis. Chest. 2005 Nov; 128(5):3276-83.
View in: PubMed

Efficacy of weekly paclitaxel in patients with docetaxel-resistant metastatic breast cancer. Breast Cancer Res Treat. 2005 Feb; 89(3):237-41.
View in: PubMed

Risk factors for endometriosis in the rhesus monkey (Macaca mulatta): a case-control study. Hum Reprod Update. 1997 Mar-Apr; 3(2):109-15.
View in: PubMed

Location

Dana-Farber Cancer Institute
450 Brookline Avenue
Dana 1112
Boston, MA 02215
Get Directions

Top